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INTRODUCTION
Several medical and surgical treatment modalities exist as 
treatment for obstructive sleep apnea (OSA).1–3 Four patho-
physiological traits seen in patients with OSA are: the passive 
critical closing pressure of the upper airway (Pcrit), arousal 
threshold, loop gain, and muscle responsiveness (PALM) with 
categories of 1, 2, 2a, 2b, and 3.4 It has been demonstrated 
that patients in four of five PALM categories will benefit from 
anatomic interventions.4 Because the dilator muscles of the 
upper airway play a critical role in maintaining an open airway 
during sleep, researchers have explored exercises and other 
airway training (singing, didgeridoo, instrument playing) that 
target oral cavity and oropharyngeal structures as a method to 
treat OSA.5–7 Myofunctional therapy (MT) and proper tongue 
positioning in the oral cavity have been described since 1918 
to improve mandibular growth, nasal breathing, and facial 
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appearance.8 Guimaraes has proposed MT as a treatment for 
OSA since the 1990s.9 MT is composed of isotonic and iso-
metric exercises that target oral (lip, tongue) and oropharyn-
geal structures (soft palate, lateral pharyngeal wall).7,10 There 
have been an increasing number of studies evaluating the ef-
fect of MT in the form of case studies, case series, and most 
recently, two randomized controlled trials.7,10–13
The most comprehensive MT exercises are described by 
Guimaraes et al.7 and involve the soft palate, tongue, and fa-
cial muscles and address stomatognathic functions. For soft 
palate exercises, patients pronounce oral vowel sounds either 
continuously (isometric exercises) or intermittently (isotonic 
exercises).7 Tongue exercises include moving the tongue along 
the superior and lateral surfaces of the teeth, positioning 
the tongue tip against the anterior aspect of the hard palate, 
pressing the entire tongue against the hard and soft palate, and 
forcing the tongue onto the floor of the mouth.7 Facial exercises 
address the lip (i.e., contraction and relaxation of the orbicu-
laris oris), buccinators (i.e., suction movements and application 
of intraoral finger pressure against the buccinator muscles), 
and jaw muscles (i.e., lateral jaw movements).7 In addition, sto-
matognathic functions are addressed by instructing patients to 
inhale nasally and exhale orally without and then with balloon 
inflation, and performing specific swallowing and chewing 
exercises (i.e., swallowing with the teeth clenched together, 
tongue positioned in the palate and without contraction of 
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perioral muscles; alternating chewing sides).7 A newer study 
describes a device that conditions and strengthens oral and 
tongue muscles.12
The objective of this study is to systematically review the 
literature for articles evaluating MT or oral/oropharyngeal ex-
ercises as treatment for OSA in both children and adults and 
to perform a meta-analysis on the available polysomnographic 
and sleepiness data.
METHODS
Search Strategy
A search was performed on Web of Science, Scopus, MED-
LINE, and The Cochrane Library, initially January 18, 2014, 
with an update on June 18, 2014. MeSH terms and keywords 
used for the search included various combinations of the fol-
lowing: “myofascial reeducation,” “myofunctional therapy,” 
“obstructive sleep apnea,” “orofacial myotherapy,” “oral myo-
therapy,” “oropharyngeal exercises,” “sleep,” “sleep apnea 
syndromes,” “speech therapy,” “upper airway exercises,” and 
“upper airway remodeling.” One example of a MEDLINE 
search is: (((“Myofunctional Therapy”[MeSH]) AND “Sleep 
Apnea Syndromes”[MeSH])) OR (“sleep” AND (“myofascial 
reeducation” OR “myofunctional therapy” OR “orofacial myo-
therapy” OR “oral myotherapy” OR “oropharyngeal exercises” 
OR “speech therapy” OR “upper airway exercises” OR “upper 
airway remodeling”)).
For each of the searches, the titles and abstracts were 
screened and the full text versions of articles that met criteria 
were downloaded. Full texts were reviewed and any refer-
enced articles that were not already obtained were ordered and 
obtained. “Related citations” were also reviewed during the 
searches, and the “cited by” function on Google Scholar was 
also used to identify any additional studies.
Study Selection
Criteria for inclusion included peer-reviewed studies (pub-
lished articles or abstracts) evaluating oral or oropharyngeal 
MT as an isolated treatment for either adult or pediatric OSA; 
studies needed to report quantitative polysomnographic, 
snoring, and/or sleepiness data pretreatment and posttreatment 
or they needed to report the percentage of difference between 
pretreatment and posttreatment outcomes. All languages 
were included. Exclusion criteria included studies evaluating 
singing, instrument playing, and studies without quantitative 
data. If individual patient data were reported and patients lost 
10% or more of their body weight, then those patients were 
excluded. Studies in which the MT patients also underwent ad-
ditional interventions such as continuous positive airway pres-
sure therapy, mandibular advancement device therapy, sleep 
apnea surgery, allergy management, weight loss management, 
or any other intervention that could also contribute to im-
proved sleep apnea outcomes were excluded (unless the addi-
tional interventions were performed in control groups and the 
data were provided separately for both MT and control groups).
Data Abstraction and Study Quality Assessment
Authors MC, JA, and SZ independently performed a 
search of the literature and screened titles and abstracts and 
downloaded the articles for inclusion. The decision to include 
the articles was made by consensus, and if necessary the final 
decision was made by author MC. Data collected included 
patient age, body mass index (BMI), polysomnographic data 
(AHI, lowest oxygen saturation), snoring, and sleepiness data. 
If data were missing from the articles, then the corresponding 
author was contacted in an attempt to obtain the data. The cor-
responding author of the study by Suzuki et al.12 was contacted 
and confirmed that the reported oxygen saturation data were 
for lowest oxygen saturation and that tongue training was in-
volved as part of the MT device training.
The National Institute for Health and Clinical Excellence 
(NICE) quality assessment tool was used to evaluate the quality 
of the included studies. The instrument consists of eight items 
that are assessed for each individual study.
Statistical Analysis
The statistics were performed with the IBM Statistical 
Package for Social Sciences software (SPSS) version 20.0 (Ar-
monk, New York, USA). Means and standard deviations were 
calculated before and after myofunctional therapy. Studies 
providing raw patient data without means and standard de-
viations were manually input into SPSS for calculation; or if 
individual scatterplots with pretreatment and posttreatment 
data were available, the estimated data point values were used 
to calculate the means and standard deviations. The null hy-
pothesis for this study is that there is no difference in outcome 
data before and after myofunctional therapy. For combining 
data, a two-tailed, paired t test was performed (P < 0.05 
was the cutoff for significance). Review Manager (RevMan) 
[Computer program] Version 5.3 (Copenhagen: The Nordic 
Cochrane Centre, The Cochrane Collaboration, 2014) was 
used for meta-analysis. A random-effects model was used if 
heterogeneity existed and a fixed-effects model was used if no 
heterogeneity existed. When pooling the data in studies, the 
means, standard deviations, and 95% confidence intervals (CI) 
were calculated by REVMAN. Heterogeneity was assessed by 
I 2 statistic (inconsistency levels: low = 25%, moderate = 50% 
and high = 75%)14 and the Cochran Q statistic (with significant 
heterogeneity being considered when P ≤ 0.1 was obtained).15 
If heterogeneity existed, then a sensitivity analysis was per-
formed by removing each of the studies individually to iden-
tify the source(s).
The Preferred Reporting Items for Systematic Reviews and 
Meta-Analysis (PRISMA) guidelines were downloaded and 
followed during this review.16
RESULTS
A total of 226 studies were screened for relevance, and 
204 were excluded. After identification of 22 potentially rel-
evant studies, they were downloaded and the reviews of the 
reference lists yielded an additional 6 studies, for a total of 
28 studies.7–13,17–36 Nine were review articles,8,20,22,27,30,32–34,36 
two reported no intervention,24,31 two studied lip exercises and 
the effect on lip thickness,21,37 one reported breathing exer-
cises not involving oral cavity or oropharyngeal structures,28 
one was a letter to the editor,11 and two studies were abstracts 
in which data were later reported in the authors’ journal ar-
ticles.19,25 Eleven studies met criteria and were included in 
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this review. Individual patient data were reported by one pe-
diatric study35 and one adult study,12 whereas the remaining 
nine studies reported outcomes with means and standard de-
viations.7,9,10,13,17,18,23,26,29 Figure 1 summarizes the flow for study 
selection.
Methodological Quality of the Included Studies
The studies included in this review included one abstract,26 
one retrospective case report,23 three retrospective case se-
ries,9,10,18 three prospective case series,12,17,29 one randomized 
trial,35 and two randomized controlled trials.7,13 Most of the 
studies satisfied four to six of the eight NICE quality assess-
ment tool items (presented in Table S1 of supplemental ma-
terial). The main limitations were that the total number of 
patients in most studies was low, the studies 
were at single institutions (except one that 
was multicentered) and most studies did not 
explicitly state that patients were consecutive.
Adult Studies
A total of nine adult studies (120 patients, 
age 44.5 ± 11.6 y, BMI 28.9 ± 6.2 kg/m2) 
reported polysomnography and/or sleepi-
ness outcomes (Table 1). Baz et al.17 reported 
using American Academy of Sleep Medicine 
(AASM) scoring criteria but did not specify 
which year, Diaferia et al.13 and Guimaraes 
et al.7 reported using 1999 AASM scoring 
criteria, Suzuki et al.12 scored based on the 
2005 update to AASM scoring criteria, and 
the remaining five studies did not specify 
which polysomnography scoring criteria 
were used.9,18,23,26,29
The pre- and post-MT AHI mean ± stan-
dard deviation (M ± SD; 82 patients) de-
creased from 24.5 ± 14.3/h to 12.3 ± 11.8/h, 
with a mean difference (MD) of −14.26 [95% 
CI −20.98, −7.54], Z score of 4.16 (P < 0.0001) 
(Figure 2). Both the I 2 statistic (91%) and the Q statistic (value 
of < 0.00001) demonstrated significant heterogeneity; therefore, 
studies were individually excluded to identify the source(s). 
Exclusion of the studies by Suzuki et al.12 and Berreto et al.18 
resulted in no heterogeneity in the remaining 73 patients, with 
the I 2 statistic = 0% and the Q statistic value of 0.6. The mean 
difference for the remaining studies was −10.49 26 [95% CI 
−12.67, −8.31]. In adult studies in which MT was performed 
for at least 3 mo, the mean AHI reduced from 25.2 ± 14.6/h to 
12.6 ± 12.2/h, which is a 50% reduction.
The lowest oxygen saturation improved in 82 patients 
from 83.9 ± 6.0% to 86.6 ± 7.3%, MD of 4.19 [95% CI 1.85, 
6.54], with an overall Z score of 3.5 (P = 0.0005); see Figure 3. 
Both the I 2 statistic (59%) and the Q statistic (value of 0.05) 
Figure 1—Flow diagram demonstrating myofunctional therapy for obstructive sleep apnea 
(OSA) study selection. N, number of articles.
Table 1—Adult pre- and post-myofunctional therapy outcomes. 
Authors, Year
Study 
Design N
Age
(years)
BMI
(kg/m²)
AHI (events/h) low O2 (%) ESS
Pre-MT Post-MT Pre-MT Post-MT Pre-MT Post-MT
Suzuki et al., 2013* PCS 6 22.0 ± 0.5 23.8 ± 1.8 15.1 ± 3.4 9.2 ± 1.5 90.0 ± 2.9 96.8 ± 0.8 – – 
Kronbauer et al., 2013 PCS 8 (40–65) – – – – – 11.75 4.25
Diaferia et al., 2013 RCT 27 45.2 ± 13.0 25.0 ± 7.4 28.0 ± 22.7 13.9 ± 18.5 83.7 ± 7.7 84.9 ± 8.8 13.7 ± 3.2 7.5 ± 3.7
Baz et al., 2012 PCS 30 44.1 ± 7.5 33.6 ± 2.0 22.3 ± 4.5 11.5 ± 5.4 84 ± 4 87 ± 5 16.4 ± 2.0 9.3 ± 2.9
Guimaraes et al., 2009 RCT 16 51.5 ± 6.8 29.6 ± 3.8 22.4 ± 4.8 13.7 ± 8.5 83 ± 6 85 ± 7 14 ± 5 8 ± 6
de Paula Silva et al., 2007 RCR 1 60 23.3 44 3 83 92 – –
Berreto et al., 2007 RCS 2 46 ± 12.7 24.2 ± 2.9 44.5 ± 5.7 6.0 ± 3.7 78 ± 1.4 85 ± 2.8 12.5 ± 0.7 4.5 ± 3.5
Guimaraes et al., 2003 ABS 10 – – 36.1 11.3 – – 11 7.6
Guimaraes et al., 1999 RCS 20 (33–55) – –  −48% – – – –
Total 120 44.5 ± 11.6 28.9 ± 6.2 24.5 ± 14.3 12.3 ± 11.8 83.9 ± 6.0 86.6 ± 7.3 14.8 ± 3.5 8.2 ± 4.1
*Study authors confirmed the reported oxygen saturation data was for lowest oxygen saturation. –, not reported, %, percent; ABS, abstract; AHI, apnea-
hypopnea index; BMI, body mass index; ESS, Epworth Sleepiness Scale; events/h, events per hour; kg/m2, kilograms per meter squared; low O2, lowest 
oxygen saturation; MT, myofunctional therapy; N, number of myofunctional therapy patients in the study; PCS, prospective case series; RCR, retrospective 
case report; RCS, retrospective case series; RCT, randomized controlled trial. 
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demonstrated significant heterogeneity, therefore, studies 
were individually excluded to identify the source(s). Exclusion 
of the studies by Suzuki et al.12 and Berreto et al.18 resulted 
in no heterogeneity in the remaining 73 patients, with the I 2 
statistic = 0% and the Q statistic value of 0.56. Oxygen desatu-
ration index was reported by one study, and demonstrated a 
reduction from 14.53 ± 5.04 to 9.27 ± 4.27, pre- and post-MT, 
respectively.17 Sleepiness decreased in all studies reporting the 
outcome. The Epworth Sleepiness Scale (ESS)38 decreased in 
75 patients from 14.8 ± 3.5 to 8.2 ± 4.1, MD of −6.81 [95% CI 
−7.79, −5.82], with an overall Z score of 13.55 (P < 0.00001); see 
Figure 4. Both the I 2 statistic (0%) and the Q statistic (value of 
0.8) demonstrated no heterogeneity.
Snoring
Snoring changes were evaluated by 4 studies, Baz et al.,17 
Berreto et al.,18 de Paula Silva et al.23 and Guimaraes et al.7; 
see Table 2. Baz et al.17 reported that 30 patients snored before 
therapy and 16 snored after therapy, P = 0.008 (yes versus no; 
article did not specify if patient or bed partner was asked) and 
the polysomnography demonstrated that the percent of total 
sleep time spent snoring decreased from 14.05 ± 4.89% to 
3.87 ± 4.12% (before and after, respectively), P < 0.001.17 Gui-
maraes et al.7 found snoring frequency decreased by 25% (ar-
ticle did not specify if patient or bed partner was asked) from 
4 to 3 (based on 0 = never to 4 = everyday), P = 0.001, and 
the snoring intensity decreased by 66% from 3 to 1 (based on 
1 = similar to breathing and 3 = very loud) with P = 0.001; 
whereas the control groups had no change in snoring frequency 
or intensity. The case study by de Paula Silva et al.23 demon-
strated a decrease in snoring intensity after 8 sessions. Ber-
reto et al.18 described two patients who decreased from a (bed 
partner) snoring score of 3 down to 2 (0 = snoring absence, 
1 = heavy breathing, 2 = light snoring, 3 = snoring that disturbs 
the bed partner and 4 = snoring that can be heard outside the 
bedroom).
Figure 3—Adult premyofunctional and postmyofunctional therapy outcomes for lowest oxygen saturation (percent). CI, confidence interval; MT, myofunctional 
therapy; SD, standard deviation; Tx, treatment.
Figure 2—Adult premyofunctional and postmyofunctional therapy outcomes for apnea-hypopnea index (events per hour). CI, confidence interval; 
MT, myofunctional therapy; SD, standard deviation; Tx, treatment.
Figure 4—Adult premyofunctional and postmyofunctional therapy outcomes for Epworth Sleepiness Scale. CI, confidence interval; MT, myofunctional 
therapy; SD, standard deviation; Tx, treatment. 
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Pediatric Studies
A total of two pediatric studies (25 patients, age 8.4 ± 3.1 y) 
reported polysomnography and/or sleepiness outcomes. Both 
pediatric studies reported using 2007 AASM scoring criteria, 
and Guilleminault et al.10 also specified that hypopneas were 
scored with a 50% reduction in nasal cannula curve and an 
associated 3% or more reduction in oxygen saturation and/or 
with associated arousals, while Villa et al.35 did not specify the 
hypopnea scoring criteria. The study by Villa et al.35 was a 
prospective randomized controlled trial in which postadeno-
tonsillectomy patients were randomized to either oropharyn-
geal exercises or control group. The treatment group in this 
study consisted of 14 patients and the pre- and post-MT AHI 
was evaluated after 2 mo of oropharyngeal exercises. The AHI 
M ± SD reduced from 4.87 ± 3.0/h to 1.84 ± 3.2/h, P = 0.004 
(a 62% reduction).35 The control group had minimal change 
in AHI during the 2-mo period (4.56/h down to 4.11/h).35 The 
study by Guilleminault et al.10 was a retrospective chart review, 
evaluating 24 children who were cured by the combination 
of adenotonsillectomy and palatal expansion (AHI 0.4 ± 0.3); 
and 11 of the children received MT (intervention group) and 13 
children did not receive MT (controls).10 At the 4-y follow-up, 
the children who practiced MT over the long term remained 
cured of OSA (AHI 0.5 ± 0.4), compared to children who were 
never trained to perform the exercises and subsequently had 
a recurrence of OSA (AHI 5.3 ± 1.5/h).10 Although both pedi-
atric MT studies compared the intervention groups to control 
groups, neither study reported pretreatment and posttreatment 
lowest oxygen saturation or sleepiness outcomes.
DISCUSSION
This systematic review and meta-analysis of nine adult and 
two pediatric studies evaluating the effect of MT on OSA has 
five main findings. First, MT provides a reduction in AHI of 
approximately 50% in adults and 62% in children. The pre- 
and post-MT AHI for adults decreased from 24.5 ± 14.3/h to 
12.3 ± 11.8/h, MD of −14.26 [95% CI −20.98, −7.54] (P < 0.0001). 
For pediatric patients, the pre- and post-MT M ± SD for AHI 
decreased from 4.87 ± 3.0/h to 1.84 ± 3.2/h, P = 0.004. Ad-
ditionally, the study by Guilleminault et al.10 reported that 11 
children remained cured of OSA (AHI of 0.5 ± 0.4/h) after con-
tinuing MT for 4 y. There was heterogeneity, and the studies 
by Suzuki et al.12 and Berreto et al.18 were shown to be the 
sources. The study by Suzuki et al.12 had six patients, who used 
an oral exercise device to help train, but the length of time 
between polysomnography was 2 mo, whereas the remaining 
adult studies reporting AHI had a follow-up duration of at least 
3 mo between polysomnography studies. Had the study been 
extended to 3 mo, there may have been additional improve-
ment in AHI. In studies with control groups, there was little to 
no improvement in the AHI for the control groups compared 
to improvement in the MT intervention group. There is also 
a clear improvement in lowest oxygen saturation by approxi-
mately 3–4%, with the meta-analysis of 81 patients demon-
strating a mean difference pre- and post-MT of 4.19%, [95% 
CI 1.85, 6.54]. The oxygen desaturation index (ODI) was only 
reported by Baz et al.,17 demonstrating a 36% reduction, but the 
article did not specify whether the ODI in the study was based 
on 3% or 4% desaturation.
Second, MT decreases snoring both subjectively and objec-
tively. Four studies compared the pre- and post-MT outcomes 
and it was noted that snoring decreased after therapy (three 
of four studies quantified the snoring). The polysomnography 
demonstrated a 72.4% reduction in snoring pre- versus post-
MT (14.05 ± 4.89% to 3.87 ± 4.12%, before and after, respec-
tively), P < 0.001.17 With regard to subjective improvement in 
snoring intensity, the three studies quantifying the outcomes 
reported that during posttreatment there was a decrease in 
snoring to either light snoring, or the sound was similar to 
normal breathing.
Third, subjective sleepiness also improves post-MT as 
demonstrated by a clear reduction in ESS score for the 93 
patients in which it was administered, with a reduction from 
14.8 ± 3.5 to 8.2 ± 4.1 (in 75 patients in whom M ± SDs were 
reported).7,13,17,18,26,29 The posttreatment ESS is below the 
threshold for hypersomnia, which is generally considered to 
be 11 or higher on the scale.39 Additionally, the 1999 study 
by Guimaraes9 reported a subjective reduction in sleepi-
ness; however, the use of a validated sleepiness scale was not 
specified.9
Fourth, despite the heterogeneity in oral and oropharyngeal 
exercises, overall the improvements in polysomnographic out-
comes and sleepiness were consistent. MT was performed for 
as little as 5 min, twice daily, 4 days a week for 2 mo12 to as 
many as 10 min, three to five times daily for 3 mo.17 The lon-
gest published experience with MT for adult OSA has been 
that of Guimaraes,9 which is 6 mo. Guimaraes9 has also pub-
lished thorough instructions for performing the exercises that 
involve the soft palate, tongue, facial muscles, and stomato-
gnathic functions to be performed 30 min a day.7
Fifth, future research is needed to help explain the patho-
physiology and mechanism of action of MT as treatment for 
Table 2—Snoring outcomes based on mean values pre and post-myofunctional therapy.
Authors, Year N
Subjective Snoring PSG %TST Snoring
Pre-MT Post-MT Pre-MT Post-MT
Baz et al., 2012 30 Yes = 30; No = 0 Yes = 16; No = 14 14.05 ± 4.89% 3.87 ± 4.12% 
Guimaraes et al., 2009 16 Very loud Similar to breathing – –
de Paula Silva et al., 2007 1 Snoring Decreased snoring – –
Berreto et al., 2007 2 Disturbs bedpartner Light snoring – –
MT, myofunctional therapy; %TST, percentage of total sleep time. Snoring outcomes are based on quantified definitions pre- and post-myofunctional 
therapy by all studies except de Paula Silva et al. (case report).
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OSA. It can be hypothesized that the exercises improve oral 
and/or oropharyngeal muscle tone and also may decrease the 
amount of fatty deposition of the tongue, but this has not been 
proven. It can be recommended that future researchers con-
sider using the standardized exercises, which have been devel-
oped and used over a period of several years by Guimaraes et 
al.7 because they have the most experience with the therapy. As 
pointed out by Guimaraes et al.,7 because MT is based on an 
integrative approach with several exercises, it is not possible to 
determine the effects of specific exercises to determine which 
ones contribute the most to improvement in outcomes7; there-
fore, future studies could consider exploring the effect of indi-
vidual exercises. Individual patient data were not available for 
most studies; therefore, a subanalysis could not be performed 
for BMI, AHI, age, etc. based on the current literature. How-
ever, with regard to BMI, Guimaraes et al.7 and Baz et al.17 
had significant reductions in AHI in overweight (BMI M ± SD 
29.6 ± 3.8) and obese patients (BMI M ± SD 33.6 ± 2.0). With 
regard to age, the MT has been shown effective in children and 
adults of all ages studied thus far, ranging from 3 to 60 y.
Limitations
A total of 145 patients (including 25 children) were included 
in this meta-analysis; however, the magnitude of the effects 
was highly significant. Although there were nine adult studies, 
a significant limitation for pediatric studies is that currently 
only two articles have been published. Additionally, long-term 
follow-up for more than 6 mo is limited. Except the study by 
Guilleminault et al,10 which followed patients for 4 y, all of the 
other studies spanned 2 to 6 mo. The study by Guilleminault 
et al.10 demonstrates a long-term (4 y) maintenance of reduc-
tion in AHI and alleviation of OSA symptoms in patients who 
continued to perform MT exercises, compared to the control 
group that had recurrence of symptoms and recurrence of an 
elevated AHI at 4-y follow-up.10 Because this is the only study 
that has reported outcomes longer than 6 mo after initiation of 
MT exercises, additional long-term studies are needed to dem-
onstrate the lasting effects of continued MT. Questions that 
have not been addressed that could be studied in the future 
include whether there is a relationship with the tongue exer-
cises and changes in the tongue and palatal muscle tone and/
or strength, tongue size (tongue fat), and overall upper airway 
volume changes pretreatment and posttreatment.
CONCLUSION
Current literature demonstrates that myofunctional therapy 
decreases AHI by approximately 50% in adults and 62% in 
children. Lowest oxygen saturation, snoring, and sleepiness 
outcomes improve in adults. Myofunctional therapy could 
serve as an adjunct to other OSA treatments.
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SUPPLEMENTAL MATERIAL
Table S1—General characteristics of included patients and quality criteria of included studies.
General Characteristics Quality Assessment of Included Studies a
Authors, Year Site Design N Follow-up BMI Outcomes Analyzed 1 2 3 4 5 6 7 8
Pediatric Studies 
Villa et al., 2014 Italy RT 14 2 mo 21.6 AHI, O2 sat No Yes Yes Yes Yes No Yes Yes
Guilleminault et al., 2013 USA RCS 11 4 y – AHI, O2 sat Yes Yes Yes Yes No No Yes Yes
Adult Studies
Suzuki et al., 2013 Japan PCS  6 2 mo 23.8 AHI, O2 sat No Yes Yes Yes Yes No Yes No
Kronbauer et al., 2013 Brazil PCS  8 2.5 mo – ESS, physical measurements No Yes No Yes Yes No Yes No
Diaferia et al., 2013 Brazil RCT 27 3 mo 25.0 AHI, AI, ESS, O2 sat No Yes Yes Yes Yes Yes Yes Yes
Baz et al., 2012 Egypt PCS 30 3 mo 33.6 AHI, ESS, O2 sat, snoring No Yes Yes Yes Yes No Yes No
Guimaraes et al., 2009 Brazil RCT 16 3 mo 29.6 AHI, AI, ESS, O2 sat, snoring No Yes Yes Yes Yes No Yes Yes
de Paula Silva et al., 2007 Brazil RCR  1 – 23.3 AHI, O2 sat, sleepiness, snoring NA NA NA NA NA NA NA NA
Berreto et al., 2007 Brazil RCS  2 4 mo 24.2 AHI, ESS, O2 sat, snoring No No No Yes No No No No
Guimaraes et al., 2003 Brazil ABS 10 – – AHI, ESS NA NA NA NA NA NA NA NA
Guimaraes et al., 1999 Brazil RCS 20 6 mo – AHI, sleepiness No Yes No Yes Yes No Yes No
aQuality assessment of cases series studies checklist from National Institute for Health and Clinical Excellence (NICE): (1) Case series collected in more 
than one center,i.e.,multicenter study? (2) Is the hypothesis/aim/objective of the study clearly described? (3) Are the inclusion and exclusion criteria 
(case definition) clearly reported? (4) Is there a clear definition of the outcomes reported? (5) Were data collected prospectively? (6) Is there an explicit 
statement that patients were recruited consecutively? (7) Are the main findings of the study clearly described? (8) Are outcomes stratified? (e.g., by disease 
stage,abnormal test results, patient characteristics)? –, not reported; AI, apnea index; AHI, apnea-hypopnea index; ESS, Epworth Sleepiness Scale; mo, 
months; N, number of patients with intervention; NA, not applicable; O2 sat, oxygen saturation; PCS, prospective case series; RCR, retrospective case 
report; RCS, retrospective case series; RCT, randomized controlled trial; RT, randomized trial; y, years.
